本页面由Tiger Trade Technology Pte. Ltd.提供服务

九洲大药房

1.52
0.0000
成交量:- -
成交额:8,935.93
市值:939.11万
市盈率:-0.96
高:1.52
开:1.52
低:1.52
收:1.52
52周最高:3.59
52周最低:1.29
股本:617.84万
流通股本:362.66万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-1.5803
每股收益(LYR):-2.9318
净资产收益率:-29.67%
总资产收益率:-3.98%
市净率:0.44
市盈率(LYR):-0.52

数据加载中...

2024/11/15

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/03

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/07/30

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/04/16

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/12

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/06/16

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/14

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/01/23

SEC问询函

CORRESP [Cover] - Correspondence
2022/12/15

SEC问询函

CORRESP [Cover] - Correspondence
2022/12/15

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/11/23

SEC问询函

CORRESP [Cover] - Correspondence
2022/10/19

SEC问询函

CORRESP [Cover] - Correspondence
2022/09/15

SEC问询函

CORRESP [Cover] - Correspondence
2022/08/05

SEC问询函

CORRESP [Cover] - Correspondence
2022/07/28

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/04/27

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/11/04

SEC问询函

CORRESP [Cover] - Correspondence
2021/06/29

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/05/14

重要事件披露

8-K - Current report
2021/04/22

重要事件披露

8-K - Current report